Home » Topics » Conferences

Conferences
RSS

Novel split-intein-based gene therapy strategy to treat Wilson disease

Oct. 27, 2021

CRISP/Cas9 modulation of utrophin as a strategy to treat DMD

Oct. 27, 2021

188Re-Rituximab shows promise for treating CD20-overexpressing cancers

Oct. 27, 2021

Ec1-LoPE DARPin-toxin fusion protein evaluated with trastuzumab for ovarian cancer

Oct. 27, 2021

VY-NPC101, a potential NPC1-based gene therapy strategy for Niemann-Pick disease type C

Oct. 27, 2021

Oxytocin receptor hypermethylation tied to obsessive-compulsive disorder

Oct. 26, 2021

Gluk2-targeted siRNA-based gene therapy for drug-resistant temporal lobe epilepsy

Oct. 26, 2021

AKAP11 identified as shared risk gene in bipolar disorder and schizophrenia

Oct. 26, 2021

CS-5001, novel ADC with promising efficacy in models of ROR1-expressing cancers

Oct. 26, 2021

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...